December 2023 Erie Insurance Company
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
ASSETS
|
Current Year |
Prior Year |
||||||||
|
1 |
2 |
3 |
4 |
||||||
|
Net Admitted Assets |
Net Admitted |
||||||||
|
Assets |
Nonadmitted Assets |
(Cols. 1 - 2) |
Assets |
||||||
|
1. |
Bonds (Schedule D) |
716,970,258 |
................................... |
716,970,258 |
743,286,632 |
||||
|
2. |
Stocks (Schedule D): |
||||||||
|
2.1 Preferred stocks |
238,750 |
................................... |
238,750 |
................................... |
|||||
|
2.2 Common stocks |
25,490,859 |
................................... |
25,490,859 |
32,492,308 |
|||||
|
3. |
Mortgage loans on real estate (Schedule B): |
||||||||
|
3.1 First liens |
................................... |
................................... |
................................... |
................................... |
|||||
|
3.2 Other than first liens |
................................... |
................................... |
................................... |
................................... |
|||||
|
4. |
Real estate (Schedule A): |
||||||||
|
4.1 Properties occupied by the company (less $ |
|||||||||
|
encumbrances) |
................................... |
................................... |
................................... |
................................... |
|||||
|
4.2 Properties held for |
the production of income (less |
||||||||
|
$ |
encumbrances) |
................................... |
................................... |
................................... |
................................... |
||||
|
4.3 Properties held for sale (less $ |
|||||||||
|
encumbrances) |
................................... |
................................... |
................................... |
................................... |
|||||
|
5. |
Cash ($ |
(567,341) , Schedule E - Part 1), cash equivalents |
|||||||
|
($ |
................. 11,343,408 |
, Schedule E - Part 2) and short-term |
|||||||
|
investments ($ |
, Schedule DA) |
10,776,067 |
................................... |
10,776,067 |
5,638,949 |
||||
|
6. |
Contract loans (including $ |
................................... premium notes) |
................................... |
................................... |
................................... |
................................... |
|||
|
7. |
Derivatives (Schedule DB) |
................................... |
................................... |
................................... |
................................... |
||||
|
8. |
Other invested assets (Schedule BA) |
1,252,411 |
410,119 |
842,292 |
871,565 |
||||
|
9. |
Receivable for securities |
1,165,439 |
................................... |
1,165,439 |
1,337,352 |
||||
|
10. |
Securities lending reinvested collateral assets (Schedule DL) |
10,001,471 |
................................... |
10,001,471 |
13,251,293 |
||||
|
11. |
Aggregate write-ins for invested assets |
................................... |
................................... |
................................... |
................................... |
||||
|
12. |
Subtotals, cash and invested assets (Lines 1 to 11) |
765,895,255 |
410,119 |
765,485,136 |
796,878,099 |
||||
|
13. |
Title plants less $ |
charged off (for Title insurers |
|||||||
|
..............................................................................................................only) |
................................... |
................................... |
................................... |
................................... |
|||||
|
14. |
.............................................................Investment income due and accrued |
................... 7,500,435 |
................................... |
................... 7,500,435 |
................... 7,036,201 |
||||
|
15. |
Premiums and considerations: |
||||||||
|
15.1 Uncollected premiums and agents' balances in the course of collection |
82,992,722 |
1,142,063 |
81,850,659 |
72,002,935 |
|||||
|
15.2 Deferred premiums, agents' balances and installments booked but |
|||||||||
|
...................................deferred and not yet due (including $ |
|||||||||
|
............................................................earned but unbilled premiums) |
................760,175,870 |
................................... |
................760,175,870 |
................573,163,118 |
|||||
|
...................................15.3 Accrued retrospective premiums ($ |
) and |
||||||||
|
contracts subject to redetermination ($ |
) |
................................... ................................... ................................... ................................... |
16. Reinsurance:
|
....................................................16.1 Amounts recoverable from reinsurers |
...................... 144,893 |
................................... |
...................... 144,893 |
...................... 114,639 |
||
|
..........................16.2 Funds held by or deposited with reinsured companies |
...................1,995,991 |
................................... |
...................1,995,991 |
...................1,490,296 |
||
|
........................16.3 Other amounts receivable under reinsurance contracts |
........................ 10,251 |
................................... |
........................ 10,251 |
........................ 21,136 |
||
|
17. |
Amounts receivable relating to uninsured plans |
................................... |
................................... |
................................... |
................................... |
|
|
18.1 |
Current federal and foreign income tax recoverable and interest thereon .... |
................. 18,423,152 |
................................... |
................. 18,423,152 |
................. 12,665,275 |
|
|
18.2 |
Net deferred tax asset |
................... 8,396,799 |
................................... |
................... 8,396,799 |
...................7,110,502 |
|
|
19. |
......................................................Guaranty funds receivable or on deposit |
................................... |
................................... |
................................... |
................................... |
|
|
20. |
.....................................Electronic data processing equipment and software |
................................... |
................................... |
................................... |
................................... |
|
|
21. |
Furniture and equipment, including health care delivery assets |
|||||
|
($ |
) |
................................... |
................................... |
................................... |
................................... |
|
|
22. |
.........Net adjustment in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
................................... |
................................... |
|
|
23. |
.....................................Receivables from parent, subsidiaries and affiliates |
................................... |
................................... |
................................... |
................................... |
|
|
24. |
Health care ($ |
) and other amounts receivable |
................................... |
................................... |
................................... |
................................... |
|
25. |
Aggregate write-ins for other than invested assets |
................... 2,750,233 |
.......................356,783 |
................... 2,393,450 |
...................1,843,621 |
|
|
26. |
Total assets excluding Separate Accounts, Segregated Accounts and |
|||||
|
Protected Cell Accounts (Lines 12 to 25) |
............1,648,285,601 |
...................1,908,965 |
............ 1,646,376,636 |
............ 1,472,325,822 |
||
|
27. |
From Separate Accounts, Segregated Accounts and Protected Cell |
|||||
|
Accounts |
................................... |
................................... |
................................... |
................................... |
||
|
28. |
Total (Lines 26 and 27) |
1,648,285,601 |
1,908,965 |
1,646,376,636 |
1,472,325,822 |
|
|
DETAILS OF WRITE-INS |
||||||
|
1101 |
.................................... |
.................................... |
.................................... |
.................................... |
|
|
1102 |
.................................... |
.................................... |
.................................... |
.................................... |
|
|
1103 |
.................................... |
.................................... |
.................................... |
.................................... |
|
|
1198. |
Summary of remaining write-ins for Line 11 from overflow page |
................................... |
................................... |
................................... |
................................... |
|
1199. |
Totals (Lines 1101 thru 1103 plus 1198)(Line 11 above) |
||||
|
2501. |
Premium Tax Credits & Other |
2,209,710 |
356,783 |
1,852,927 |
1,778,291 |
|
2502. |
Equities and Deposits in Pools and Associations |
........................ 24,689 |
................................... |
........................ 24,689 |
........................ 54,552 |
|
2503. |
Other Accounts Receivable |
...................... 515,834 |
................................... |
...................... 515,834 |
........................ 10,778 |
|
2598. |
Summary of remaining write-ins for Line 25 from overflow page |
................................... |
................................... |
................................... |
................................... |
|
2599. |
Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) |
2,750,233 |
356,783 |
2,393,450 |
1,843,621 |
2
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
LIABILITIES, SURPLUS AND OTHER FUNDS
|
1 |
2 |
||||
|
Current Year |
Prior Year |
||||
|
1. |
Losses (Part 2A, Line 35, Column 8) |
........................................................................................................................................ |
................311,540,268 |
................274,391,970 |
|
|
2. |
.....................................Reinsurance payable on paid losses and loss adjustment expenses (Schedule F, Part 1, Column 6) |
................................... |
................................... |
||
|
3. |
.........................................................................................................Loss adjustment expenses (Part 2A, Line 35, Column 9) |
................. 45,703,860 |
................. 43,522,869 |
||
|
4. |
.............................................................................Commissions payable, contingent commissions and other similar charges |
................................... |
................................... |
||
|
5. |
...............................................................................................................Other expenses (excluding taxes, licenses and fees) |
...................... 155,695 |
...................... 182,814 |
||
|
6. |
...................................................................................Taxes, licenses and fees (excluding federal and foreign income taxes) |
...................3,910,141 |
................... 2,577,429 |
||
|
7.1 |
...................................Current federal and foreign income taxes (including $ |
on realized capital gains (losses)) |
................................... |
................................... |
|
|
7.2 |
Net deferred tax liability |
................................... |
................................... |
||
|
8. |
Borrowed money $ |
and interest thereon $ |
.......................................... |
................................... |
................................... |
9. Unearned premiums (Part 1A, Line 38, Column 5) (after deducting unearned premiums for ceded reinsurance of
|
$ |
1,925,945,474 |
and including warranty reserves of $ |
and accrued accident and |
||||
|
health experience rating refunds including $ |
for |
medical loss ratio rebate per the Public Health |
|||||
|
.............................................................................................................................................................................Service Act) |
................220,537,626 |
................185,217,229 |
|||||
|
10. |
.....................................................................................................................................................................Advance premium |
................... 4,257,130 |
................... 3,876,219 |
||||
|
11. |
Dividends declared and unpaid: |
||||||
|
......................................................................................................................................................................11.1 Stockholders |
................................... |
................................... |
|||||
|
.....................................................................................................................................................................11.2 Policyholders |
.......................343,484 |
.......................425,973 |
|||||
|
12. |
........................................................................................Ceded reinsurance premiums payable (net of ceding commissions) |
................716,546,594 |
................539,231,401 |
||||
|
13. |
Funds held by company under reinsurance treaties (Schedule F, Part 3, Column 20) |
............................................................. |
...................1,540,248 |
.......................954,173 |
|||
|
14. |
Amounts withheld or retained by company for account of others |
.............................................................................................. |
...................1,460,752 |
...................... 697,505 |
|||
|
15. |
Remittances and items not allocated |
........................ 61,526 |
...................... 109,683 |
||||
|
16. |
...................................Provision for reinsurance (including $ |
.........................certified) (Schedule F, Part 3, Column 78) |
........................ 15,000 |
................................... |
|||
|
17. |
...................................................................................Net adjustments in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
||||
|
18. |
.....................................................................................................................................................................Drafts outstanding |
................................... |
................................... |
||||
|
19. |
............................................................................................................................Payable to parent, subsidiaries and affiliates |
................. 32,269,272 |
................. 30,912,005 |
||||
|
20. |
.................................................................................................................................................................................Derivatives |
................................... |
................................... |
||||
|
21. |
................................................................................................................................................................Payable for securities |
................................... |
................................... |
||||
|
22. |
....................................................................................................................................................Payable for securities lending |
................. 10,001,471 |
................. 13,251,293 |
||||
|
23. |
......................................................................................................................Liability for amounts held under uninsured plans |
................................... |
................................... |
||||
|
24. |
Capital notes $ |
...................................and interest thereon $ |
................................................. |
................................... |
................................... |
||
|
25. |
Aggregate write-ins for liabilities |
||||||
|
26. |
Total liabilities excluding protected cell liabilities (Lines 1 through 25) |
............ 1,348,343,067 |
............ 1,095,350,564 |
||||
|
27. |
Protected cell liabilities |
||||||
|
28. |
Total liabilities (Lines 26 and 27) |
............ 1,348,343,067 |
............ 1,095,350,564 |
||||
|
29. |
............................................................................................................................Aggregate write-ins for special surplus funds |
................................... |
................................... |
||||
|
30. |
...............................................................................................................................................................Common capital stock |
...................2,350,000 |
...................2,350,000 |
||||
|
31. |
...............................................................................................................................................................Preferred capital stock |
................................... |
................................... |
||||
|
32. |
...........................................................................................................Aggregate write-ins for other than special surplus funds |
................................... |
................................... |
||||
|
33. |
.............................................................................................................................................................................Surplus notes |
................................... |
................................... |
||||
|
34. |
.......................................................................................................................................Gross paid in and contributed surplus |
................. 86,482,000 |
................. 86,482,000 |
||||
|
35. |
.......................................................................................................................................................Unassigned funds (surplus) |
............... 209,201,569 |
................288,143,258 |
||||
|
36. |
Less treasury stock, at cost: |
||||||
|
36.1 |
shares common (value included in Line 30 |
$ |
) |
................................... |
................................... |
||
|
36.2 |
shares preferred (value included in Line 31 |
$ |
) |
................................... |
................................... |
||
|
37. |
Surplus as regards policyholders (Lines 29 to 35, less 36) (Page 4, Line 39) |
298,033,569 |
376,975,258 |
||||
|
38. |
TOTALS (Page 2, Line 28, Col. 3) |
1,646,376,636 |
1,472,325,822 |
||||
|
DETAILS OF WRITE-INS |
|||||||
|
2501 |
.................................... |
||||||
|
2502 |
.................................... |
||||||
|
2503 |
.................................... |
||||||
|
2598. |
Summary of remaining write-ins for Line 25 from overflow page |
.............................................................................................. |
................................... |
................................... |
|||
|
2599. |
Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) |
||||||
|
2901 |
.................................... |
||||||
|
2902 |
.................................... |
||||||
|
2903 |
.................................... |
||||||
|
2998. |
Summary of remaining write-ins for Line 29 from overflow page |
.............................................................................................. |
................................... |
................................... |
|||
|
2999. |
Totals (Lines 2901 thru 2903 plus 2998)(Line 29 above) |
||||||
|
3201. |
...................................................................................................................................................................................................................................... |
.................................... |
3202. ........................................................................................................................................................................................................................................ ....................................
3203. ........................................................................................................................................................................................................................................ ....................................
3298. Summary of remaining write-ins for Line 32 from overflow page .............................................................................................. ................................... ...................................
3299. Totals (Lines 3201 thru 3203 plus 3298)(Line 32 above)
3
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
STATEMENT OF INCOME
|
1 |
2 |
|||
|
Current Year |
Prior Year |
|||
|
UNDERWRITING INCOME |
||||
|
1. |
Premiums earned (Part 1, Line 35, Column 4) |
473,639,029 |
419,015,959 |
|
|
DEDUCTIONS: |
||||
|
2. |
Losses incurred (Part 2, Line 35, Column 7) |
................391,335,510 |
................328,706,480 |
|
|
3. |
Loss adjustment expenses incurred (Part 3, Line 25, Column 1) |
................. 43,972,247 |
................. 43,271,380 |
|
|
4. |
Other underwriting expenses incurred (Part 3, Line 25, Column 2) |
|||
|
138,029,924 |
118,765,382 |
|||
|
5. |
Aggregate write-ins for underwriting deductions |
...................... 178,059 |
...................... 117,006 |
|
|
6. |
Total underwriting deductions (Lines 2 through 5) |
573,515,740 |
490,860,248 |
|
|
7. |
Net income of protected cells |
................................... |
................................... |
|
|
8. |
Net underwriting gain (loss) (Line 1 minus Line 6 plus Line 7) |
|||
|
................(99,876,711) |
................(71,844,289) |
|||
|
INVESTMENT INCOME |
||||
|
9. |
............................................................................Net investment income earned (Exhibit of Net Investment Income, Line 17) |
................. 26,340,120 |
................. 22,360,657 |
|
|
10. |
Net realized capital gains (losses) less capital gains tax of $ |
(Exhibit of Capital |
||
|
Gains (Losses) ) |
(17,061,100) |
(11,015,652) |
||
|
11. |
Net investment gain (loss) (Lines 9 + 10) |
9,279,020 |
11,345,005 |
|
|
OTHER INCOME |
12. Net gain (loss) from agents' or premium balances charged off (amount recovered
|
$ |
958,288 amount charged off $ |
3,284,360 |
) |
................. (2,326,072) |
................. (2,520,793) |
|
|
13. |
...........................................................................................................Finance and service charges not included in premiums |
................................... |
................................... |
|||
|
14. |
Aggregate write-ins for miscellaneous income |
23,134 |
(5,554) |
|||
|
15. |
..................................................................................................................................Total other income (Lines 12 through 14) |
(2,302,938) |
(2,526,347) |
|||
|
16. |
Net income before dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes |
|||||
|
(Lines 8 + 11 + 15) |
(92,900,629) |
(63,025,632) |
||||
|
17. |
Dividends to policyholders |
274,136 |
396,894 |
|||
|
18. |
Net income, after dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes |
|||||
|
(Line 16 minus Line 17) |
(93,174,765) |
(63,422,526) |
||||
|
19. |
Federal and foreign income taxes incurred |
(18,715,442) |
(12,821,301) |
|||
|
20. |
.......................................................................................................................Net income (Line 18 minus Line 19)(to Line 22) |
(74,459,323) |
(50,601,224) |
|||
|
CAPITAL AND SURPLUS ACCOUNT |
||||||
|
21. |
Surplus as regards policyholders, |
................376,975,258 |
................433,182,703 |
|||
|
22. |
Net income (from Line 20) |
(74,459,323) |
(50,601,224) |
|||
|
23. |
........................................................................................................................Net transfers (to) from Protected Cell accounts |
................................... |
................................... |
|||
|
24. |
Change in net unrealized capital gains or (losses) less capital gains tax of $ |
370,516 |
................. (5,641,353) |
................. (6,710,104) |
||
|
25. |
.................................................................................................Change in net unrealized foreign exchange capital gain (loss) |
........................ 33,749 |
.......................(11,879) |
|||
|
26. |
...........................................................................................................................................Change in net deferred income tax |
...................1,656,813 |
...................1,064,857 |
|||
|
27. |
Change in nonadmitted assets (Exhibit of Nonadmitted Assets, Line 28, Col. 3) |
|||||
|
..................................................................... |
(516,575) |
50,905 |
||||
|
28. |
................................................................Change in provision for reinsurance (Page 3, Line 16, Column 2 minus Column 1) |
...................... (15,000) |
................................... |
|||
|
29. |
............................................................................................................................................................Change in surplus notes |
................................... |
................................... |
|||
|
30. |
............................................................................................................Surplus (contributed to) withdrawn from protected cells |
................................... |
................................... |
|||
|
31. |
..............................................................................................................Cumulative effect of changes in accounting principles |
................................... |
................................... |
|||
|
32. |
Capital changes: |
|||||
|
32.1 Paid in |
................................... |
................................... |
||||
|
........................................................................................................................32.2 Transferred from surplus (Stock Dividend) |
................................... |
................................... |
||||
|
.......................................................................................................................................................32.3 Transferred to surplus |
................................... |
................................... |
||||
|
33. |
Surplus adjustments: |
|||||
|
33.1 Paid in |
................................... |
................................... |
||||
|
.............................................................................................................................33.2 Transferred to capital (Stock Dividend) |
................................... |
................................... |
||||
|
....................................................................................................................................................33.3 Transferred from capital |
................................... |
................................... |
||||
|
34. |
.................................................................................................................................Net remittances from or (to) Home Office |
................................... |
................................... |
|||
|
35. |
.........................................................................................................................................................Dividends to stockholders |
................................... |
................................... |
|||
|
36. |
..............................................................Change in treasury stock (Page 3, Lines 36.1 and 36.2, Column 2 minus Column 1) |
................................... |
................................... |
|||
|
37. |
..................................................................................................................Aggregate write-ins for gains and losses in surplus |
|||||
|
38. |
.......................................................................Change in surplus as regards policyholders for the year (Lines 22 through 37) |
(78,941,689) |
(56,207,445) |
|||
|
39. |
Surplus as regards policyholders, |
298,033,569 |
376,975,258 |
|||
|
DETAILS OF WRITE-INS |
||||||
|
0501. |
.................................................................................................................................................................LAD Program Expense |
...................... 178,059 |
...................... 117,006 |
|||
|
0502 |
.................................... |
|||||
|
0503 |
.................................... |
|||||
|
0598. |
................................................................................................Summary of remaining write-ins for Line 5 from overflow page |
................................... |
................................... |
|||
|
0599. |
Totals (Lines 0501 thru 0503 plus 0598)(Line 5 above) |
178,059 |
117,006 |
|||
|
1401. |
Miscellaneous Income (Loss) |
24,714 |
(4,536) |
|||
|
1402. |
...............................................................................................................................................................................State Fines and Penalties |
(1,580) |
........................ (1,018) |
|||
|
1403 |
.................................... |
|||||
|
1498. |
..............................................................................................Summary of remaining write-ins for Line 14 from overflow page |
................................... |
................................... |
|||
|
1499. |
Totals (Lines 1401 thru 1403 plus 1498)(Line 14 above) |
23,134 |
(5,554) |
|||
|
3701 |
.................................... |
3702. ........................................................................................................................................................................................................................................ ....................................
3703. ........................................................................................................................................................................................................................................ ....................................
3798. Summary of remaining write-ins for Line 37 from overflow page .............................................................................................. ................................... ...................................
3799. Totals (Lines 3701 thru 3703 plus 3798)(Line 37 above)
4
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
CASH FLOW
Cash from Operations
1
Current Year
2
Prior Year
|
1. |
Premiums collected net of reinsurance |
................489,027,942 |
................426,122,313 |
|
|
2. |
Net investment income |
................. 28,026,880 |
................. 25,006,279 |
|
|
3. |
Miscellaneous income |
(1,942,781) |
(1,898,702) |
|
|
4. |
Total (Lines 1 through 3) |
515,112,041 |
449,229,891 |
|
|
5. |
Benefit and loss related payments |
................354,217,466 |
............... 284,699,995 |
|
|
6. |
.......................................................Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts |
................................... |
................................... |
|
|
7. |
Commissions, expenses paid and aggregate write-ins for deductions |
................178,693,646 |
................157,269,238 |
|
|
8. |
Dividends paid to policyholders |
...................... 356,625 |
...................... 400,640 |
|
|
9. |
Federal and foreign income taxes paid (recovered) net of $ |
tax on capital gains (losses) |
(12,957,565) |
(3,993,830) |
|
10. |
Total (Lines 5 through 9) |
520,310,172 |
438,376,043 |
|
|
11. |
Net cash from operations (Line 4 minus Line 10) |
(5,198,131) |
10,853,848 |
|
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
|
12.1 |
Bonds |
213,843,376 |
190,905,232 |
|
12.2 |
Stocks |
962,244 |
936,634 |
|
12.3 |
Mortgage loans |
................................... |
................................... |
|
12.4 |
Real estate |
................................... |
................................... |
|
12.5 |
Other invested assets |
................................... |
................................... |
|
12.6 |
Net gains or (losses) on cash, cash equivalents and short-term investments |
................................... |
................................... |
|
12.7 |
Miscellaneous proceeds |
3,424,278 |
34 |
|
12.8 Total investment proceeds (Lines 12.1 to 12.7) |
............... 218,229,898 |
............... 191,841,901 |
13. Cost of investments acquired (long-term only):
|
13.1 |
Bonds |
205,015,397 |
213,182,476 |
|
|
13.2 |
Stocks |
1,178,750 |
................................... |
|
|
13.3 |
Mortgage loans |
................................... |
................................... |
|
|
13.4 |
Real estate |
................................... |
................................... |
|
|
13.5 |
Other invested assets |
...................... 202,500 |
...................... 902,908 |
|
|
13.6 |
Miscellaneous applications |
10,109,285 |
||
|
13.7 |
Total investments acquired (Lines 13.1 to 13.6) |
206,396,647 |
224,194,669 |
|
|
14. |
.................................................................................................Net increase/(decrease) in contract loans and premium notes |
|||
|
15. |
Net cash from investments (Line 12.8 minus Line 13.7 minus Line 14) |
11,833,251 |
(32,352,768) |
|
|
Cash from Financing and Miscellaneous Sources |
||||
|
16. |
Cash provided (applied): |
|||
|
16.1 |
Surplus notes, capital notes |
................................... |
................................... |
|
|
16.2 Capital and paid in surplus, less treasury stock |
................................... |
................................... |
||
|
.................................................................................................................................................................16.3 Borrowed funds |
................................... |
................................... |
||
|
..............................................................................16.4 Net deposits on deposit-type contracts and other insurance liabilities |
................................... |
................................... |
||
|
.................................................................................................................................................16.5 Dividends to stockholders |
................................... |
................................... |
||
|
...........................................................................................................................................16.6 Other cash provided (applied) |
(1,498,002) |
9,880,534 |
||
|
17. |
Net cash from financing and miscellaneous sources (Lines 16.1 to 16.4 minus Line 16.5 plus Line 16.6) |
(1,498,002) |
9,880,534 |
|
|
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS |
||||
|
18. |
........................................Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17) |
5,137,118 |
(11,618,386) |
|
|
19. |
Cash, cash equivalents and short-term investments: |
|||
|
...............................................................................................................................................................19.1 Beginning of year |
...................5,638,949 |
................. 17,257,335 |
||
|
19.2 End of period (Line 18 plus Line 19.1) |
10,776,067 |
5,638,949 |
Note: Supplemental disclosures of cash flow information for non-cash transactions:
5
Attachments
Disclaimer



Quartix Technologies plc, Financial Statements 2023
Caterpillar Inc.: FILES FORM 10-K FYE 31 DECEMBER 2023
Advisor News
- Equitable launches 403(b) pooled employer plan to support nonprofits
- Financial FOMO is quietly straining relationships
- GDP growth to rebound in 2027-2029; markets to see more volatility in 2026
- Health-related costs are the greatest threat to retirement security
- Social Security literacy is crucial for advisors
More Advisor NewsAnnuity News
- Best’s Special Report: Analysis Shows Drastic Shift in Life Insurance Reserves Toward Annuity Products, and a Slide in Credit Quality
- MetLife to Announce First Quarter 2026 Results
- CT commissioner: 70% of policyholders covered in PHL liquidation plan
- ‘I get confused:’ Regulators ponder increasing illustration complexities
- Three ways the Corebridge/Equitable merger could shake up the annuity market
More Annuity NewsHealth/Employee Benefits News
- Families worry their fragile peace could be at risk with Medicaid cuts
- Terry Savage: The health insurance sinkhole
- AKF STATEMENT ON RESOLUTION OF COURT CASE CHALLENGING CALIFORNIA ASSEMBLY BILL 290
- WHITEHOUSE, SULLIVAN INTRODUCE LEGISLATION TO HELP BLIND AMERICANS RETURN TO WORK
- 20 years after passing nation-leading health care law, Mass. braces for new challenges
More Health/Employee Benefits NewsLife Insurance News
- An Application for the Trademark “PREMIER ACCESS” Has Been Filed by The Guardian Life Insurance Company of America: The Guardian Life Insurance Company of America
- AM Best Assigns Credit Ratings to North American Fire & General Insurance Company Limited and North American Life Insurance Company Limited
- Supporting the ‘better late than never’ market with life insurance
- Best’s Special Report: Analysis Shows Drastic Shift in Life Insurance Reserves Toward Annuity Products, and a Slide in Credit Quality
- The child-free client: how advisors can support this growing demographic
More Life Insurance News